Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Finance and funding news

Show

From To
Gilead Ignored HIV Groups Before Failed Bid To Have PrEP Subsidised In Australia

A drug manufacturer failed to take the advice of top HIV/AIDS organisations when it made a submission for a highly effective HIV prevention drug to be subsidised by the government, those organisations say.

Published
25 August 2016
From
BuzzFeed
German medicines watchdog rejects ‘new tenofovir’ pill

The German health technology assessment agency IQWiG has announced that it finds no advantage in Descovy, a combination pill containing a new version of the HIV

Published
22 August 2016
By
Gus Cairns
HIV prevention drug Truvada won't be subsidised in Australia

Truvada, an expensive breakthrough drug that prevents people from getting HIV won't be funded by taxpayers in Australia this year, the nation's drug funding panel has ruled. A Department of Health spokeswoman said the PBAC understood "this is an important new prevention medication for HIV", but decided the price set by the drug's sponsor, Gilead Sciences, was too high and a proposal to limit subsidy to a small subset of the "at risk" group was not feasible. "In its deliberations the PBAC indicated a substantial price reduction would be needed to make Truvada available for PrEP for the whole 'at risk' population, but noted that Truvada for PrEP could represent value for money in the broader population at a substantially lower price," the spokeswoman said.

Published
19 August 2016
From
Sydney Morning Herald
Hillary Clinton calls out drug maker Gilead over price of hepatitis C pills

Democratic presidential nominee Hillary Clinton said Wednesday her administration will go after drug companies that charge exorbitant prices, singling out the company Gilead, whose hepatitis C drugs cost between $900 and $1,000 per pill in the United States.

Published
19 August 2016
From
UPI.com
Today In History, 1990: President George H.W. Bush Signs the Ryan White CARE Act

Since the earliest days of the AIDS epidemic, the nation’s response to the deadly disease was chronically slow and woefully underfunded. Much of the resistance to increased funding stemmed from open hostility to the disease’s two main risk groups; gay men and intravenous drug users.

Published
18 August 2016
From
Box Turtle Bulletin
Cancer drug companies cut prices to win NHS approval

Tougher new policy by regulator means pharma firms are having to offer better value for money to get treatments accepted by NHS.

Published
18 August 2016
From
The Guardian
The end of the end of AIDS

The Durban 2016 AIDS Conference marks the end of "ending the HIV epidemic" as a feasible goal with the tools we have. We need new and better tools. Talk of ending AIDS has led to a widespread perception in the broader health and development community that this crisis is over. It isn't.

Published
16 August 2016
From
World Bank (blog)
Brexit: What does it mean for development aid and the Global Fund?

Britain’s vote to leave the European Union has left much of the global development community wondering what this will mean for the UK’s role as a global leader in international aid and development. It also raises issues about the implications for the Global Fund’s Fifth Replenishment.

Published
03 August 2016
From
Global Fund Observer
PrEP rationing is symptomatic of NHS bid to cut costs, at all costs

NHS England’s setback in the high court over its attempt to get one set of cash-strapped public bodies (local councils) to foot the £10m-£20m a year bill for PrEP treatment rather than another – itself – is the latest manifestation of the health service’s increasing efforts to reduce the number of treatments it pays for, or the number of patients who receive them, or both.

Published
03 August 2016
From
The Guardian
High Court rules NHS England is responsible for funding PrEP

A judicial review in the High Court has ruled that NHS England is responsible for funding pre-exposure prophylaxis (PrEP) and decisively rebutted all the arguments used by

Published
02 August 2016
By
Keith Alcorn
← First12345...90Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close